Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunotherapy targeting 4-1BB and its ligand.

Dass S Vinay1, Byoung S Kwon

  • 1Department of Ophthalmology, LSU Eye Center, Louisiana State University Health Sciences Center School of Medicine, New Orleans, USA.

International Journal of Hematology
|January 31, 2006
PubMed
Summary

The 4-1BB costimulatory pathway has dual roles in immune responses. A novel CD11c(+)CD8(+) T-cell population may mediate these opposing functions of agonistic anti-4-1BB therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cross-Activation of Regulatory T Cells by Self Antigens Limits Self-Reactive and Activated CD8<sup>+</sup> T Cell Responses.

International journal of molecular sciences·2023
Same author

Phase 1 trial of 4-1BB-based adoptive T-cell therapy targeting human telomerase reverse transcriptase in patients with advanced refractory solid tumors.

Cytotherapy·2023
Same author

4-1BB-4-1BBL cis-interaction contributes to the survival of self-reactive CD8<sup>+</sup> T cell.

Cellular & molecular immunology·2023
Same author

Targeting 4-1BB and PD-L1 induces potent and durable antitumor immunity in B-cell lymphoma.

Frontiers in immunology·2022
Same author

Adoptive immunotherapy with transient anti-CD4 treatment enhances anti-tumor response by increasing IL-18Rα<sup>hi</sup> CD8<sup>+</sup> T cells.

Nature communications·2021
Same author

IL7-Fc Enhances the Efficacy of Adoptive T Cell Therapy under Lymphopenic Conditions in a Murine Melanoma Model.

Cells·2021

Area of Science:

  • Immunology
  • T-cell Biology
  • Immune Regulation

Background:

  • T-cell activation requires costimulatory signals; absence leads to anergy.
  • The 4-1BB/4-1BBL pathway is a crucial costimulatory pathway.
  • 4-1BB signaling primarily enhances CD8(+) T-cell responses, promoting cytokine induction and survival.

Purpose of the Study:

  • To investigate the dual roles of agonistic anti-4-1BB in vivo.
  • To identify the cellular mechanisms underlying the opposing functions of 4-1BB.
  • To explore the therapeutic potential of modulating the 4-1BB pathway.

Main Methods:

  • Utilized in vivo disease models.
  • Administered agonistic anti-4-1BB monoclonal antibody.
  • Analyzed T-cell populations, including a novel CD11c(+)CD8(+) subset.

Main Results:

  • Agonistic anti-4-1BB showed therapeutic effects in tumors, autoimmune diseases, and graft-versus-host disease.
  • Blockade of 4-1BB/4-1BBL was effective against viral myocarditis, keratitis, and graft rejection.
  • A novel CD11c(+)CD8(+) T-cell population was identified as potentially mediating dual functions.

Conclusions:

  • The 4-1BB pathway exhibits context-dependent dual roles in immune regulation.
  • Agonistic anti-4-1BB can promote effector functions or suppressive functions.
  • Targeting 4-1BB offers therapeutic strategies for diverse conditions, warranting further investigation of the CD11c(+)CD8(+) T-cell subset.

Related Experiment Videos